NLS Pharmaceutics’ $30 Million Purchase Agreement with BVF Partners L.P.

Federica Tiefenthaler
Tagged:

Kellerhals Carrard advised BVF on the deal while Sheppard Mullin served as counsel to Laidlaw & Company (UK) Ltd.NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here